CD274 and breast cancer: In particular, a close relationship between the upregulation of tumor-restricted PD-L1 and human CSC markers, basal cell markers and vimentin expression has been reported in invasive BC [20], as well as constitutive and inducible expression of PD-L1 in the CD44-positive CSC subset of head and neck squamous cell carcinoma [21].